Gene therapy in treating sickle cell anemia disease
Sickle cell anemia disease or in short known as SCD is an inherited and serious condition affecting the body's blood and various organs. This disease can give effects to the red blood cells that can cause sickle-like episodes that cause pain and other symptoms. People with SCD are...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Book Section |
| Language: | English |
| Published: |
Penerbit UTHM
2022
|
| Subjects: | |
| Online Access: | http://eprints.uthm.edu.my/7508/1/2.pdf http://eprints.uthm.edu.my/7508/ |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| id |
my.uthm.eprints.7508 |
|---|---|
| record_format |
eprints |
| spelling |
my.uthm.eprints.75082022-08-15T03:06:31Z http://eprints.uthm.edu.my/7508/ Gene therapy in treating sickle cell anemia disease Dol Ramli, Nur Amira Abdul Hadi, Muhammad Faris Mohamed, Elizah Mohd Fauzi, Noor Akhmazillah T Technology (General) Sickle cell anemia disease or in short known as SCD is an inherited and serious condition affecting the body's blood and various organs. This disease can give effects to the red blood cells that can cause sickle-like episodes that cause pain and other symptoms. People with SCD are generally well in between episodes of sickling which may cause a long term of complications. Certain situations may trigger sickling, like cold, low oxygen levels, infection or lack of fluid in the body (dehydration). This complication of disease can be prevented from the root with a good treatment. Therefore, early diagnosis and specialized treatment for SCD are recommended from doctors. Based on the previous research, the method used in treating this disease is stem cell transplantation that can be found in bone marrow. Actually, every transplant of bone marrow has risks and bad effects on the patient. It can give an infection to the immune system like attack the new stem cells that will cause failure to the transplant. Moreover, once the stem cell of the donor doesn't match with the recipients, the new immune system cell of donors would attack a few organs of recipients. So, these complications are very dangerous to the donors and recipients. Based on the medical biotechnology that has a lot of benefits, this research will focus on treating disease by gene therapy with CRISPR/Cas9 as a method and an adeno-associated virus (AAV) as a vector. In this research which is based on application of biotechnology, it will be focusing on gene therapy. Gene therapy is also one of the best treatments for this disease. The main reason for patients with sickle cell is causing the disorder of the adult hemoglobin gene, not the fetal hemoglobin gene during the gene mutation. So, this gene therapy in the sickle cell operates by growing the production of the selected gene by restoring the transition performance again to fetal hemoglobin, which does not sickle, and subsequently decreasing sickle hemoglobin and thereby increasing fetal hemoglobin. Penerbit UTHM Mohd Fauzi, Noor Akhmazillah Mohamed, Elizah Abdul Hadi, Muhammad Faris Dol Ramli, Nur Amira Murugananthan, Yuggheshinie 2022 Book Section PeerReviewed text en http://eprints.uthm.edu.my/7508/1/2.pdf Dol Ramli, Nur Amira and Abdul Hadi, Muhammad Faris and Mohamed, Elizah and Mohd Fauzi, Noor Akhmazillah (2022) Gene therapy in treating sickle cell anemia disease. In: CHEMICAL PROCESS AND SUSTAINABILITY IN MEDICAL BIOTECHNOLOGY. Penerbit UTHM, UTHM, pp. 13-28. |
| institution |
Universiti Tun Hussein Onn Malaysia |
| building |
UTHM Library |
| collection |
Institutional Repository |
| continent |
Asia |
| country |
Malaysia |
| content_provider |
Universiti Tun Hussein Onn Malaysia |
| content_source |
UTHM Institutional Repository |
| url_provider |
http://eprints.uthm.edu.my/ |
| language |
English |
| topic |
T Technology (General) |
| spellingShingle |
T Technology (General) Dol Ramli, Nur Amira Abdul Hadi, Muhammad Faris Mohamed, Elizah Mohd Fauzi, Noor Akhmazillah Gene therapy in treating sickle cell anemia disease |
| description |
Sickle cell anemia disease or in
short known as SCD is an inherited and
serious condition affecting the body's
blood and various organs. This disease can
give effects to the red blood cells that can
cause sickle-like episodes that cause pain
and other symptoms. People with SCD are
generally well in between episodes of
sickling which may cause a long term of
complications. Certain situations may
trigger sickling, like cold, low oxygen levels,
infection or lack of fluid in the body
(dehydration). This complication of disease
can be prevented from the root with a good
treatment. Therefore, early diagnosis and
specialized treatment for SCD are
recommended from doctors. Based on the
previous research, the method used in
treating this disease is stem cell
transplantation that can be found in bone
marrow. Actually, every transplant of bone
marrow has risks and bad effects on the
patient. It can give an infection to the
immune system like attack the new stem
cells that will cause failure to the transplant.
Moreover, once the stem cell of the donor
doesn't match with the recipients, the new
immune system cell of donors would attack
a few organs of recipients. So, these
complications are very dangerous to the
donors and recipients. Based on the
medical biotechnology that has a lot of
benefits, this research will focus on treating
disease by gene therapy with CRISPR/Cas9
as a method and an adeno-associated virus
(AAV) as a vector. In this research which is
based on application of biotechnology, it
will be focusing on gene therapy. Gene
therapy is also one of the best treatments
for this disease. The main reason for
patients with sickle cell is causing the
disorder of the adult hemoglobin gene, not
the fetal hemoglobin gene during the gene
mutation. So, this gene therapy in the sickle
cell operates by growing the production of
the selected gene by restoring the transition
performance again to fetal hemoglobin,
which does not sickle, and subsequently
decreasing sickle hemoglobin and thereby
increasing fetal hemoglobin. |
| author2 |
Mohd Fauzi, Noor Akhmazillah |
| author_facet |
Mohd Fauzi, Noor Akhmazillah Dol Ramli, Nur Amira Abdul Hadi, Muhammad Faris Mohamed, Elizah Mohd Fauzi, Noor Akhmazillah |
| format |
Book Section |
| author |
Dol Ramli, Nur Amira Abdul Hadi, Muhammad Faris Mohamed, Elizah Mohd Fauzi, Noor Akhmazillah |
| author_sort |
Dol Ramli, Nur Amira |
| title |
Gene therapy in treating sickle cell anemia disease |
| title_short |
Gene therapy in treating sickle cell anemia disease |
| title_full |
Gene therapy in treating sickle cell anemia disease |
| title_fullStr |
Gene therapy in treating sickle cell anemia disease |
| title_full_unstemmed |
Gene therapy in treating sickle cell anemia disease |
| title_sort |
gene therapy in treating sickle cell anemia disease |
| publisher |
Penerbit UTHM |
| publishDate |
2022 |
| url |
http://eprints.uthm.edu.my/7508/1/2.pdf http://eprints.uthm.edu.my/7508/ |
| _version_ |
1743109093122375680 |
| score |
13.211869 |